-
Krakowsky J,
Morgan M,
Canal C,
Pathare P,
Avery K,
Reichelt A,
Hartsel J,
Nivorozhkin A,
Inamder A,
Varty G (December 2022). "ACNP 61st
Annual Meeting: Poster...
- June 2014.
Archived from the
original on 13
September 2016.
Pacher P,
Nivorozhkin A, Szabó C (March 2006). "Therapeutic
effects of
xanthine oxidase inhibitors:...
-
Health Service.
Archived from the
original on 4
March 2012. Pacher, P.;
Nivorozhkin, A.; Szabó, C. (2006). "Therapeutic
effects of
xanthine oxidase inhibitors:...
-
Avery K,
Morgan ME,
Reichelt AC,
Pathare P,
Stang E,
Palfreyman MG,
Nivorozhkin A.
Synthesis and Structure-Activity
Relationships of 2,5-Dimethoxy-4-Substituted...
- Histopathology. 17 (3): 755–60. doi:10.14670/HH-17.755. PMID 12168784.
Pacher P,
Nivorozhkin A, Szabó C (March 2006). "Therapeutic
effects of
xanthine oxidase inhibitors:...
-
Avery K,
Morgan ME,
Reichelt AC,
Pathare P,
Stang E,
Palfreyman MG,
Nivorozhkin A (April 2024). "Synthesis and Structure-Activity
Relationships of 2...
-
caffeic acid, is only a weak
inhibitor of
xanthine oxidase.
Pacher P,
Nivorozhkin A, Szabó C (March 2006). "Therapeutic
Effects of
Xanthine Oxidase Inhibitors:...
- doi:10.3390/ijms232415777. PMC 9779201. PMID 36555419. US 2023/0357147,
Nivorozhkin A,
Palfreyman M, "Deuterated
tryptamine derivatives and
methods of use"...
- 1038/s41386-023-01756-4. PMC 10729596. PMID 38040810. WO 2023156450,
Nivorozhkin A, JA Hartsel,
Canal CE,
Salituro FG,
Mueller TA,
Greene BJ,
Belser A...
-
Nachtschatten Verlag AG. pp. 789–791. ISBN 978-3-03788-700-4. WO 2023/156450,
Nivorozhkin A,
Hartsel JA,
Canal CE,
Salituro FG,
Mueller TA,
Greene BJ,
Belser A...
